Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. (Q33356908)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. |
scientific article |
Statements
Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously (English)
Owen O'Connor
Howard Scher
Wm Kevin Kelly
Victoria M Richon
Tracy Curley
Barbara MacGregor-Curtelli
William Tong
Lawrence Schwartz
Stacie Richardson
Eddie Rosa
Carlos Cordon-Cordo
Judy H Chiao
Richard Rifkind
1 September 2003